Novo Nordisk Cash on Hand 2012-2026 | NVO

Novo Nordisk cash on hand for the quarter ending March 31, 2026 was $4.024B, a 36.87% decline year-over-year.

  • Novo Nordisk cash on hand for 2025 was $5.094B, a 7.65% increase from 2024.
  • Novo Nordisk cash on hand for 2024 was $4.732B, a 0.05% increase from 2023.
  • Novo Nordisk cash on hand for 2023 was $4.73B, a 27% increase from 2022.

Novo Nordisk Cash on Hand 2012-2026 | NVO

  • Novo Nordisk cash on hand for 2025 was $5.094B, a 7.65% increase from 2024.
  • Novo Nordisk cash on hand for 2024 was $4.732B, a 0.05% increase from 2023.
  • Novo Nordisk cash on hand for 2023 was $4.73B, a 27% increase from 2022.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$887.6B
Johnson & Johnson (JNJ)$574.4B
AbbVie (ABBV)$367.7B
Roche Holding AG (RHHBY)$318.8B
Merck (MRK)$299.9B
Novartis AG (NVS)$294B
Pfizer (PFE)$153.1B
Sanofi (SNY)$114B
Bayer (BAYRY)$46.2B
Innoviva (INVA)$1.8B